Revisiting the Plasmodium falciparum druggable genome using predicted structures and data mining

Area of Science:

• Parasitology
• Drug Discovery
• Genomics

Background:

• Identifying novel antimalarial drug targets is crucial for combating malaria.
• Traditional methods for target identification are time-consuming and resource-intensive.
• Existing drug discovery efforts are limited by compound libraries and assay conditions.

Purpose of the Study:

• To systematically identify and prioritize novel Plasmodium falciparum (P. falciparum) protein targets for antimalarial drug development.
• To overcome limitations of traditional target identification methods by leveraging protein structure prediction.
• To create a genome-wide resource and a generalizable framework for pathogenic disease target evaluation.

Main Methods:

• Genome-wide assessment of P. falciparum proteins using protein structure prediction.
• Identification of targets with evidence of small-molecule binding and blood-stage essentiality.
• Expert review and rubric-based scoring for selectivity, structural information, and assay developability.

Main Results:

• Identified 867 candidate protein targets with binding potential and essentiality.
• Filtered to 540 proteins with strong essentiality and no clinical trial inhibitors.
• Prioritized 27 high-value antimalarial target candidates based on multiple criteria.

Conclusions:

• A novel, systematic framework using protein structure prediction accelerates antimalarial target discovery.
• The study provides a valuable genome-wide data resource for P. falciparum research.
• The identified 27 targets represent promising candidates for developing new antimalarial drugs.